Funding

Orthogon Therapeutics

United States · Biotech

Develops antiviral drugs for polyomavirus infections

Visit orthogontherapeutics.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Undisclosed$11MParticipants not disclosed

Investors

No participants disclosed.

Coverage

Apr 17, 2026Orthogon Therapeutics · Undisclosed

Similar companies

Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
iCUREXKagoshima medical-device company developing chitosan hydrogel materials for wound care, including the syringe-delivered Kitosla CX dressing.¥140M · Series A first close: equity and debt
Sourcesorthogontherapeutics.com ↗